Cafepharma Detail Piece Daily Pharma Headlines Archive

Recent
2017
2016
2015
2014
2013
2012
2011
2010

Click a link below to view the mailing archive as if it had been sent to you.

2017-07-21 12:15AstraZeneca CEO reassures staff, aims to be at September cancer meet and more...
2017-07-21 00:15Amgen and Novartis ID the finish line in a wicked scramble for first CGRP migraine drug OK and more...
2017-07-20 12:15Sanofi offers Ablynx billions of biobucks for nanobody partnership and more...
2017-07-20 00:15How AbbVie Could Hammer Gilead's Hepatitis C Franchise and more...
2017-07-19 12:15Biotech M&A? Novartis chief Jimenez says he’s sticking to the under-$1B aisle for now and more...
2017-07-19 00:15'Just What We Dreamed.' New Vertex Drugs Show Dramatic Benefit Against Cystic Fibrosis and more...
2017-07-18 12:15Takeda relocates hundreds of R&D, vaccine staffers and cuts 480 in sales: report and more...
2017-07-18 00:15This Secretive Clan Wants to Beat the World’s Biggest Drugmakers and more...
2017-07-17 12:153 Small Biotech Stocks Being Run by Proven Winners and more...
2017-07-17 00:15Pfizer Is Set to Lose Its No. 1 Spot Among Drugmakers: Here's Why It Doesn't Matter and more...
2017-07-15 12:15From ‘Rain Man’ to ‘Pied Piper,’ Shkreli's actions confounded Retrophin executives and more...
2017-07-15 00:15Will he stay or will he go? AZ's shares jump, Teva's sink on report that Soriot will stay put
2017-07-14 12:15Insurance giant takes Insys to court for 'creative, fraudulent, and illegal' opioid promotion scheme and more...
2017-07-14 00:15Cancer-fighting PARP drugs from AstraZeneca, Clovis and Tesaro largely overpriced, watchdog says and more...
2017-07-13 12:155 Pharma & Biotech Stocks That Could Be Big Winners in Q2 Earnings and more...
2017-07-13 00:15Novartis wins unanimous support from FDA panel on groundbreaking CAR-T med and more...
2017-07-12 12:15D-day: Novartis arrives at a crossroad in the blockbuster race to win the first FDA OK for CAR-T and more...
2017-07-12 00:15HPV Infection Rates Plummet With Vaccination and more...
2017-07-11 12:15Teva accuses former executive of siphoning trade secrets to her rival CEO boyfriend and more...
2017-07-11 00:15These 5 Cancer Drugs Will Be the Biggest Winners 5 Years From Now and more...
2017-07-10 12:15How Reproducible are Preclinical Study Results? and more...
2017-07-10 00:15What the FDA's Hold on Three Merck Studies Means for Other Drug Makers and more...
2017-07-09 12:15How Shrewd of a Dealmaker Is Gilead Sciences? Just Look at Its Last 7 Acquisitions and more...
2017-07-09 00:15Will Johnson & Johnson's Dividend Keep Climbing?
2017-07-08 12:15Capillary Biomedical takes aim at ‘the Achilles heel of diabetes’ and more...
2017-07-08 00:15J&J turns its back on Capricor and its failed stem cell tech, taking its money and rep with it and more...
2017-07-07 12:15Feds’ case spotlights Shkreli’s disastrous biotech short — which forced him to launch Retrophin and more...
2017-07-07 00:15Amgen, Teva hikes show pharma can't blame rebates for all price increases: analyst and more...
2017-07-06 12:15Ex-AstraZeneca executive Luke Miels accuses CEO Soriot of threatening him for taking GSK job and more...
2017-07-06 00:15Industry paid $8.2B to docs, hospitals last year and more...
2017-07-05 12:15Shire will cut U.S. locations and move HQ in consolidation push and more...
2017-07-05 00:15Martin Shkreli's lawyer objects to gag order, blames media and client's 'frail emotional state' for courthouse rant and more...
2017-07-04 00:15Shkreli’s Social Media Antics Don't Slow During Fraud Trial and more...
2017-07-03 12:15Martin Shkreli blasts prosecutors as 'junior varsity,' says investor wasn't 'victim' and criticizes headlines in lunch visit to reporters and more...
2017-07-02 12:15Can Celgene, Bluebird Keep Their Lead As Rivals Champ At The Bit? and more...
2017-07-01 12:15The Importance of the Safety Management Plan for Clinical Trials and more...

Please enter all required fields
Correct invalid entries
 

Subscribe >>

 
 
 

SPONSORED:  Are you running to the pharmacy every month or so to refill prescriptions? Here’s a service that could simplify your life — and save you a little money. Phil is a prescription refill service that delivers your prescription right to your door at no extra cost. It talks to your insurance company to handle payment issues and renew refills, so you don’t have to. Plus, as a new customer, you can get up to $20 off your first prescription.

Phil partners with local pharmacies to have your prescriptions delivered. You’ll keep your insurance and the same copay you’re paying now. Partner pharmacies pay to use the company’s software, so there are no extra fees for you

You can get started with Phil here.

 

Contact Us

Past Issues

Unsubscribe